Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Result of AGM

29 Jul 2021 16:41

RNS Number : 9755G
Volex PLC
29 July 2021
 

29 July 2021

 

Volex plc

("Volex" or the "Company")

 

Voting Results for the Company's 2021 Annual General Meeting ("AGM")

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is pleased to announce the results of its AGM, held earlier today, at which all resolutions were duly passed on a poll. Votes were cast as follows:

 

Resolution

Percentage in Favour*

Votes

For

Votes Against

Votes Withheld*

Total votes cast

Percentage of issued share capital voted

1. To receive the audited accounts of the Company for the financial year ended 4 April 2021

 

 

99.99%

97,714,691

744

78,277

97,793,712

61.61%

2. To approve the Remuneration Committee Report

 

 

81.33%

73,729,782

16,924,869

7,139,061

97,793,712

61.61%

3. To declare a final dividend of 2.2 pence per Ordinary Share for the financial year ended 4 April 2021

 

 

99.99%

97,793,007

705

0

97,793,712

61.61%

4. To elect Jon Boaden as a Director of the Company

 

 

99.99%

97,785,901

2,744

5,067

97,793,712

61.61%

5. To elect Amelia Murillo as a Director of the Company

 

99.80%

97,595,575

194,005

4,132

97,793,712

61.61%

6. To elect Sir Peter Westmacott as a Director of the Company

 

99.65%

97,448,159

340,486

5,067

97,793,712

61.61%

7. To re-appoint PricewaterhouseCoopers LLP as auditors of the Company

 

 

98.30%

96,126,321

1,662,559

4,832

97,793,712

61.61%

8. To authorise the Directors to determine the remuneration of the auditors

98.31%

96,136,021

1,652,624

5,067

97,793,712

61.61%

9. To authorise the Directors to allot shares in the Company pursuant to section 551 of the Companies Act 2006 (the "2006 Act")

 

 

99.53%

97,331,449

460,567

1,696

97,793,712

61.61%

10. To authorise the Directors to allot equity securities under the authority conferred by Resolution 9 as if section 561 of the 2006 Act did not apply

 

 

95.48%

93,374,868

4,417,148

1,696

97,793,712

61.61%

11. To further authorise the Directors, in addition to any authority granted under Resolution 10 and only in connection with an acquisition or specified capital investment, to allot equity securities as if section 561 of the 2006 Act did not apply

 

 

95.48%

93,425,093

4,418,148

1,696

97,844,937

61.64%

12. To authorise the Company to make purchases of its own shares in accordance with section 701 of the 2006 Act

 

 

99.97%

97,557,162

28,042

259,733

97,844,937

61.64%

 

 

*A vote withheld is not treated as a vote in law and is not counted in the calculation of the proportion of the votes cast for or against a resolution.

 

Resolutions 1 to 9 were ordinary resolutions, requiring a simple majority of votes cast to pass, while resolutions 10 to 12 were special resolutions, requiring at least 75% support to pass.

The total number of Volex shares in issue on Tuesday 26 July 2021 was 158,718,709.

 

The full text of each of the resolutions is set out in the Notice of AGM, which is available on the Volex website (www.volex.com) on the "Shareholder Information" page in the Investor Relations section.

 

 

For further information please contact:

 

Volex plc

+44 (0)7971 156 431

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Christian Bedford, Group General Counsel and Company Secretary

 

Singer Capital Markets - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

Iqra Amin

James Fischer

 

HSBC Bank plc - Joint Broker

+44 (0)20 7991 8888

Simon Alexander

Joe Weaving

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDKCBQPBKDKOB
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.